1. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine;Adams;J. Pharmacol. Exp. Therapeut.,1990
2. Immunopharmacotherapies for treating opioid use disorder;Banks;Trends Pharmacol. Sci.,2018
3. Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis;Bertalmio;J. Pharmacol. Exp. Therapeut.,1989
4. Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands;Bergman;Psychopharmacology,2000
5. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine;Broadbear;J. Pharmacol. Exp. Therapeut.,2000